Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging

NCT03078192 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Vascular Disease

Interventions

DRUG: GE-141, Hyperpolarized 129Xenon gas
DEVICE: MRI

Sponsor

Bastiaan Driehuys

Collaborators

[object Object]